Open AccessPrediction of Pretreatment 18F-FDG-PET/CT Parameters on the Outcome of First-Line Therapy in Patients with Metastatic Breast Cancer
Author(s) -
Yi Li,
Cheng Liu,
Bibo Wang,
Xichun Hu,
Chengcheng Gong,
Yannan Zhao,
Yizhao Xie,
Yingjian Zhang,
Shaoli Song,
Zhongyi Yang,
Biyun Wang
Publication year - 2021
Publication title -
international journal of general medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.722
H-Index - 36
ISSN - 1178-7074
DOI - 10.2147/ijgm.s293998
Subject(s) - medicine , metastatic breast cancer , breast cancer , standardized uptake value , positron emission tomography , progression free survival , nuclear medicine , population , stage (stratigraphy) , oncology , log rank test , cancer , survival analysis , overall survival , paleontology , environmental health , biology
18F-uorodeoxyglucose positron emission tomography/computed tomography (18F-FDG-PET/CT) can provide prognostic information, especially 18F-FDG uptake has been proven to be a predictor for the prognosis of various tumors. Nevertheless, the prognosis of other PET parameters in the metastatic setting remains unclear. This study was aimed at investigating pretreatment parameters based on 18F-FDG-PET/CT so as to estimate the progression-free survival (PFS) of metastatic breast cancer (MBC) patients receiving first-line treatment.